Is insulin an independent predictor of mortality in hemodialysis patients?;Da li je insulin nezavisan prediktor preživljavanja hemodijaliznih bolesnika?

Jugoslovenska Medicinska Biohemija

Volumn 23, Issue 1, 2004, Pages 43-49

  Rasic Milutinovic, Zorica ^a,f   Peruničić, Gordana ^b   Plješa, Steva ^b   Ristić, Vanja ^c   Ristić, Gordana ^c   Milić, Nataša ^d   Ilić, Mirka ^e  

^a Klin Bolnickog Centra Zemun Beograd   (Serbia)

^b Odeljenje za Nefrologiju i Dijalizu   (Serbia)

^c Institut za Medicinska Istraivanja   (Serbia)

^d Medicinski fakultet   (Serbia)

^e Institut za Medicinsku Biohemiju   (Yugoslavia)

^f Klini ko bolni ki centar 'Zvezdara'   (Serbia)

Author keywords

Dyslipidemia; End stage renal failure; Glucose intolerance; Hemodialysis; Insulin resistance; Malnutrition

Indexed keywords

ALBUMIN; C PEPTIDE; CREATININE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INSULIN; LIPID; LIPOPROTEIN; LIPOPROTEIN A; UREA;

ADULT; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; CAUSE OF DEATH; DYSLIPIDEMIA; FOLLOW UP; GLUCOSE INTOLERANCE; HEMODIALYSIS; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN RESPONSE; INSULIN SENSITIVITY; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALNUTRITION; MORTALITY; PROTEIN DEGRADATION; SURVIVAL;

EID: 1842511802     PISSN: 03543447     EISSN: None     Source Type: Journal    
DOI: 10.2298/JMH0401043R     Document Type: Article

References (35)

1. Lowrie EG, Lew NL. Death risk in hemodialysis patients. The predictive value of commonlt measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 1990; 15: 458-82.
2. Locatelli F, Del Vecchio L, Manzoni C. Morbidity and mortality on maintenance haemodialysis. Nephron 1998; 80: 380-400.
3. Brunner FP, Selwood NH. Results of renal replacement therapy in Europe, 1980 to 1987. Am J Kidney Dis 1990; 15: 384-96.
4. Charra B, Calemard E, Ruffet M et al. Survival as an index of adequacy of dialysis. Kidney Int 1992; 41: 1286.
5. Garibotto G. Muscle amino acid metabolism and the control of muscle protein turnover in patients with chronic renal failure. Nutrition 1999; 15: 145-55.
6. Bergstrom J, Wang T, Lindholm B. Factor contributing to catabolism in end-stage disease patients. Miner Electrolyte Metab 1998; 24: 92-101.
7. Stenvinkel P, Heimburger O, Lindholm B, Kaysen GA, Bergstrom J. Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrol Dial Transplant 2000; 15: 953-960.
8. Stenvinkel P, Holmberg I, Heimburger O, Diczfalusy U. A study of plasmalogen as index of oxidative stress in patients with chronic renal failure. Evidence of increased oxidative stress in malnourished patients. Nephrol Dial Transplant 1998; 13: 2594-600.
9. Fontbonne A, Eshwege E, Cambine F et al. Hypertriglyceridemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from 11-years follow up of the Paris prospective study. Diabetologia 1989; 32: 300-94.
10. Pyorala K, Savolainen E, Kaukola S, Haapakoski J. Plasma insulin as coronary heart disease rsk factor: relationship to other risk factors and predicitve value during 9 † year folow up of the Helsinki Policemen population. Acta Med Scand Suppl 1985; 701: 38-52.
11. Castelli WP. Epidemiology of coronary heart disease: the Framingham study. Am J Med 1984; 76 (Suppl. 2A): 4-12.
12. Bonora E, Willeit J, Kiechl S et al. U-Shaped and J-shaped relationsips between serum insulin and coronary heart disease in the general population. Diabetes Care 1998;21:221-30.
13. Ma KW, Greene EJ, Raij L et al. Cardiovascular risk factors in chronic renal failure and hemodialysis populationa Am J Kidney Dis 1992; 19: 505-13.
14. De Fronzo RA, Alvestrand A, Smith D, Hendler R, Hendler E, Wahren J. Insulin resistance in uremia. J Clin Invest 1981; 67: 563-70.
15. Mak RHK. Renal disease, insulin resistance and glucose intolerance. Diabetes Rev 1994; 2: 19-28.
16. Stumvoll M, Meyer C, Mitrakou A, Nadkarni V, Gerich JE. Renal glucose production and utilisation: new aspects in humans. Diabetologia 1997; 40: 749-57.
17. Smith D, De Fronzo RA. Insulin resistance in uremia mediated by postbinding defects. Kidney Int 1982; 22: 54-62.
18. Friedman JE, Dohm GL, Elton CW, et al. Muscle insulin resistance in uremic humans: glucose transport, glucose transporters, and insulin receptors. Am J Physiol 1991; 261: E87-94.
19. Foss MC, Gouvela LM, Neto MM, Paccola GM, Piccinato CE. Effect of hemodialysis on periferal glucose metabolism of patients with chronic renal failure. Nephron 1996; 73: 48-53.
20. Jinn-Yuh Guh, Hung-Chun Chen, Hung-Yi Chuang, Su-Chen Huang, Li-Chu Chien, Yung-Hsiung Lai. Risk factors and risk for mortality of mild hypoparathyroidism in hemodialysis patients. Am J Kidney Dis 2002; 39: 1245-54.
21. Trinder P. Determination of glucose in blood using glucose oxidase with and alternative oxygen accepter. Ann Clin Biochem 1969; 6: 24-7.
22. World Health Organisation Expert Committee on Diabetes Mellitus (1985) Second Report. World Health Organisation (Tech. Rep. Ser. No. 727) Geneva, Switzerland.
23. Allain CC, Poon LS, Chan CSG, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem 1974; 2-:470-5.
24. Study Group European Atherosclerosis Society. Strategies for the prevention of coronary heart disease: A policy statement of the European Atherosclerosis Society. Eur Heart J 1987; 8: 77.
25. Friedewald WT, Levi RI, Fredrickson DS. Estimation of concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
26. Steinmetz JN. Antisera to human apolipoprotein A1 and B. Eur J Clin Chem Clin Biohem 1995; 33: 337.
27. Bisse E, Abraham EC. New less temperature sensitive microchromatographic method for separation and quantitation of glycosylated hemoglobins using a non-cyanide buffer system. J Chromatog 1985; 344: 81-91
28. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-9.
29. Gotch FA, Sargent JA. A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int 1985; 28: 526-34.
30. Prentice RL, Kalbfleisch JD. Hazard rate models with covariates. Biometrics 1979 35: 25-39.
31. Balkau B, Shipley M, Jarrett J, Pyorala K, Pyorala M, Forhan A. et al. High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. Diabetes Care 1998; 21: 360-7.
32. Rašić-Milutinović Z, Peruničić -Peković G, Bokan Lj, Plješa S, Ristić V, Tepsić V. Hyperinsulinism in hyperliporoteinaemia in chronic hemodialysis patients. Med Pregl 1997; L(5-6): 220-3.
33. Peruničić-Pekovi G, Rašić-Milutinović Z, Bokan Lj, Plješa S, Tepsić V and Ristić V. Visceral protein status and hyperlipoproteinemia in hemodialysis patients. Med Pregl 1997; L (3-4): 112-4.
34. 3 corrects insulin and lipid abnormalities in uremia. Kidney Int 1998; 53: 1353-7.
35. Foley RN, Parfrey P, Harnnet J et al. The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J Am Soc Nephrol 1995; 5: 2024-31.